amylin vs glp-1 GLP-1s Agonists: Emerging Obesity and Diabetes Treatment | Ted Kyle posted on the topic 💡 𝗘𝘃𝗲𝗿𝘆𝗼𝗻𝗲'𝘀 𝘁𝗮𝗹𝗸𝗶𝗻𝗴 𝗮𝗯𝗼𝘂𝘁 𝗚𝗟𝗣-𝟭𝘀.

De Giorgi and colleagues present a comprehensive analysis of pre-clinical and clinical studies examining the role of glucagon-like peptide-1 receptor agonists in mental disorders.

Discontinuing GLP-1 RA leaves our patients unsupported in their battle against the inevitable weight regain that occurs as a consequence of physiological forces, such as an increase in appetite and reduction in metabolic rate

Understanding your genetic predispositions and metabolic biomarkers can support more informed treatment conversations

When fiber reaches the colon, beneficial gut bacteria ferment it into short-chain fatty acids (SCFAs), which stimulate the release of GLP-1

Maze Law offers legal representation to help you secure compensation for your medical injuries